VIPpharma ApS: Financial statements 2025
CVR: 38744763
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
VIPpharma ApS (CVR 38744763) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 2,432,365 and a net result of DKK 674,851 compared with DKK 1,191,483 the year before. That is a decrease of 22.5% compared with the year before. Equity in the 2025 report amounted to DKK 1,263,395. The solvency ratio was 54.9%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 2,432,365
- Profit/Loss
- DKK 674,851
- Equity
- DKK 1,263,395
- Total Assets
- DKK 2,302,809
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 2.4 mio. | 675 t. | 1.3 mio. | 2 |
| 2024 | - | 3.1 mio. | 1.2 mio. | 1.8 mio. | 2 |
| 2023 | - | 2.6 mio. | 743 t. | 1.7 mio. | 2 |
| 2022 | - | 2.4 mio. | 634 t. | 2 mio. | 2 |
| 2021 | - | 2.1 mio. | 428 t. | 2.4 mio. | 2 |
Official annual report
How creditworthy is VIPpharma ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
VIPpharma ApS has published its annual report for 2024. Gross profit came to DKK 3,138,702, and the net result was DKK 1,191,483.
About VIPpharma ApS
VIPpharma ApS is a Danish company of the type Anpartsselskab based in Karlslunde, founded in 2017. The company is registered under the industry Public relations og kommunikation. The management consists of Vibeke Wærens. The company is owned by VIPinvest ApS. The company has 3 employees (2018). In 2025, the company reported a gross profit of DKK 2,432,365 and a net result of DKK 674,851 compared with DKK 1,191,483 the year before. Equity in the 2025 report amounted to DKK 1,263,395.